Summary
This valuable agent can now be used as an adjuvant (preventative) fashion in patients with gastrointestinal stroma tumors (GIST)
Analysis
Not a major coup BUT will increase the use by a minimum of 33% in this unusual but not that rare tumor type.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
